Medlab Clinical (ASX: MDC) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Medlab Clinical Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Medlab Clinical (ASX: MDC)
Latest News
⏸️ Investing
Here are 2017's best performing ASX pot stocks
⏸️ Investing
Here's Medlab Clinical Ltd's 'world first' plan to test cannabis on Sydney patients
❮2
MDC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Medlab Clinical
Medlab Clinical Ltd. engages in the development of therapeutic pathways for diagnosed chronic diseases. It operates through the Nutraceutical Sales and Pharmaceutical Research segments. Its products include BifidoBiotic, BioClean, Biotic Jnr., GastroDaily, Lactoferrin Enhanced, Manuka-C, NanoCelle, NeuroActiv, NRGBiotic, and ORSBiotic. The company was founded by Sean Hall on June, 2012 and is headquartered in Botany, Australia.
